Fig. 9: Tumour neoantigens and immune evasion mechanisms by subtype.
From: Genomic landscape of diffuse glioma revealed by whole genome sequencing
A Presence of immune evasion mechanisms by tumour subtype (Yes indicating tumours with at least one immune evasion mechanism, otherwise No); B Clonal neoantigen mutations across glioma subtypes and presence of immune evasion mechanism. Unadjusted two-sided P-values estimated from Kruskal-Wallis test between indicated tumour subsets with sample numbers indicated in brackets. In the box plots, the centre line represents the median, and the box bounds represents the inter-quartile range. Total n = 403.
